| Date | Title | Description |
| 13.12.2024 | The Rise of Plant-Based Innovation: Lallemand's Role in Revolutionizing Food | The food landscape is changing. The shift towards plant-based diets is not just a trend; it’s a movement. At the forefront of this revolution is Lallemand Specialty Cultures, a Canadian company that is redefining how we think about cheese a... |
| 12.12.2024 | Lallemand Specialty Cultures Contributes to Project Revolutionizing Plant-Based Cheese Through Fermentation | Lallemand Specialty Cultures, a unit of Canadian company Lallemand focused on solutions for cheese, fermented meats, and plant-based alternatives, has revealed its role in Bel Group’s Cocagne Project.
The project will create fermented and r... |
| 08.01.2024 | Canadian Yeast Specialist Lallemand Acquires Swiss Biotech Company Evolva | Lallemand Inc., a Canadian company specializing in yeast-based ingredients, has confirmed that its subsidiary Danstar Ferment AG has acquired Swiss biotech company Evolva AG.
Similarly to Lallemand, Evolva is focused on researching, develop... |
| 23.11.2023 | Evolva: a CHF 20 million exit deal prevents company closure | |
| 24.08.2022 | Swiss biotechs in dispute with regulators | |
| 08.02.2022 | Evolva appoints Christian Wichert as new CEO to boost growth strategy and enter its next phase of development and commercialization | Evolva Holding SA / Key word(s): Personnel
Evolva appoints Christian Wichert as new CEO to boost growth strategy and enter its next phase of development and commercialization
08-Feb-2022 / 07:01 CET/CEST
Release of an ad hoc announcement pu... |
| 27.12.2021 | Evolva secures additional financing lines to accelerate its growth | EQS-Ad-hoc: Evolva Holding SA / Key word(s): Financing
Evolva secures additional financing lines to accelerate its growth
27-Dec-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible... |
| 30.11.2021 | Evolva announces private placement of 63.8m shares to VERAISON raising gross proceeds of CHF 7.5m and CFO departure | EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous
Evolva announces private placement of 63.8m shares to VERAISON raising gross proceeds of CHF 7.5m and CFO departure
30-Nov-2021 / 07:01 CET/CEST
Release of an ad hoc announcem... |
| 10.09.2021 | Evolva : HY 2021 Results Presentation (EN) | HY 2021
Results presentation
August 26, 2021
Agenda
Highlights 4
Strategic priorities 7
Business update 15
Financials 24
Outlook 28
© EVOLVA HY 2021 RESULTS PRESENTATION 26 August 2021 2
Disclaimer
The shares of Evolva Holding ("Evolva... |
| 26.08.2021 | Evolva : Half Year Results presentation 2021 (EN) | HY 2021
Results presentation
August 26, 2021
Agenda
Highlights 4
Strategic priorities 7
Business update 15
Financials 24
Outlook 28
© EVOLVA HY 2021 RESULTS PRESENTATION 26 August 2021 2
Disclaimer
The shares of Evolva Holding ("Evolva... |
| 17.05.2021 | EVOLVA HOLDING SA
Evolva : secures additional funding for future growth | EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous
Evolva secures additional funding for future growth
17-May-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for ... |
| 03.12.2020 | The People’s Vaccine—Moderna’s Coronavirus Vaccine Was Largely Funded By Taxpayer Dollars | Coronavirus Covid-19 Protection and Vaccine. getty |
| 24.09.2020 | Aquatic biopesticide startup Sundew closes $1.7m seed round | As with terrestrial livestock, pests and diseases can wreak havoc on fish farms. But some of today’s aquatic chemical treatments, which are often toxic and non-degradable, bring wider environmental and food safety headaches. Besides that, p... |
| 20.10.2017 | SPECIAL REPORT: Navigating the vanilla flavors market | Vanilla bean prices surged in the early 2000s before crashing and then stabilizing for some years, Edouard Janssen, SVP and general manager at Solvay Aroma Performance, Americas, told FoodNavigator-USA.
However, prices have surged again sin... |
| 10.08.2016 | Evolva collaborates with US Navy | Evolva’s collaboration with US Navy to focus on resveratrol-based composites |
| 27.07.2016 | ETH spin-off develops solution for Zika Virus | |
| 05.07.2016 | A Closer Look at Cellular Agriculture and the Processes Defining It | Editor’s Note: Cellular agriculture is a method of agricultural production enabling the growth of meat, eggs, and leather in cell culture rather than raising and slaughtering livestock. Next week, scientists and producers spearheading cellu... |
| 28.09.2015 | Synthetic Biology Is Not Just Good, It’s Good For You | Emily Leproust Contributor
Emily Leproust is CEO of Twist Bioscience.
More posts by this contributor
Beyond The $1K Genome: DNA ‘Writing’ Comes Next
Synthetic biology (synbio for short) is a term that circulates freely through the tech worl... |
| 26.08.2015 | Lux Research: Cost, speed & sustainability benefits of synthetic biology will make it a ‘permanent and growing aspect' of flavors market | While definitions of synthetic biology vary – and some firms feel the ‘synbio’ moniker is unhelpful – the technique typically involves producing ingredients [eg. flavors, sweeteners, oils] in bioreactors via a fermentation process using mic... |
| 21.08.2015 | 5 Questions with Tate & Lyle Ventures as Firm Launches Second Food Tech Fund | Focusing on investments in high-growth companies innovating in the field of food sciences and technologies, Tate & Lyle Ventures launched in 2006 as the venture capital arm of UK-based global food company Tate & Lyle, best known for... |
| 21.11.2014 | Nützliche Phantasie und konkrete Politik | |
| 24.09.2014 | Synthetic biology is cheaper, faster, and more sustainable, says Evolva CEO: 'We’re proud of what we do' | And if what emerges from the fermentation process is chemically indistinguishable from what is extracted from a stevia leaf, or vanilla seed pod, does the fact ‘synthetic biology’ has made it possible mean it’s dangerous, unnatural and unre... |
| 28.08.2014 | So Häagen-Dazs ‘says no to synbio’? | Now asking a company a question, getting the answer and using this as the hook for a press release that supports your 'narrative' is standard practice in PR, but FOE's creative interpretation of some pretty innocuous company statements in o... |
| 06.03.2013 | Evolva to raise up to CHF 31.3 million | Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) today announces the start of its capital increase. Evolva will raise up to CHF 31.3 million by means of a rights issue to existing shareholders. The new shares will be priced at CHF 0.... |
| 14.07.2010 | Cleveland Clinic-led cardiovascular technology incubator aims high | “The thing that attracted us most to the Clinic and the GCIC was its blending of science and technology with the drive for commercialization,” said John Griffin, director of the Science and Innovation Division of the Ohio Department of Deve... |
| - | Cleveland Clinic-led cardiovascular technology incubator aims high | The Global Cardiovascular Innovation Center incubator building is beginning to fill up.
The $19-million, 50,000-square-foot building on the southern edge of the Cleveland Clinic’s main campus opened quietly in April. The goal of the Ohio Th... |
